Mindy I. Davis

8.7k total citations · 2 hit papers
38 papers, 4.6k citations indexed

About

Mindy I. Davis is a scholar working on Molecular Biology, Cell Biology and Oncology. According to data from OpenAlex, Mindy I. Davis has authored 38 papers receiving a total of 4.6k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 8 papers in Cell Biology and 7 papers in Oncology. Recurrent topics in Mindy I. Davis's work include Metal-Catalyzed Oxygenation Mechanisms (7 papers), Computational Drug Discovery Methods (5 papers) and Protein Kinase Regulation and GTPase Signaling (4 papers). Mindy I. Davis is often cited by papers focused on Metal-Catalyzed Oxygenation Mechanisms (7 papers), Computational Drug Discovery Methods (5 papers) and Protein Kinase Regulation and GTPase Signaling (4 papers). Mindy I. Davis collaborates with scholars based in United States, Germany and Canada. Mindy I. Davis's co-authors include Lisa Wodicka, Pietro Ciceri, Daniel K. Treiber, Patrick P. Zarrinkar, Jeremy P. Hunt, Edward I. Solomon, Michael Höcker, Gabriel Pallares, Sanna Herrgård and Frank Neese and has published in prestigious journals such as Cell, Chemical Reviews and Proceedings of the National Academy of Sciences.

In The Last Decade

Mindy I. Davis

37 papers receiving 4.5k citations

Hit Papers

Comprehensive analysis of kinase inhibitor selec... 1999 2026 2008 2017 2011 1999 500 1000 1.5k

Peers

Mindy I. Davis
Charles Eigenbrot United States
A. Tulinsky United States
David E. Heppner United States
Andreas C. Joerger United Kingdom
Simon P. Fricker United Kingdom
J. A. Bertrand United States
Timothy C. Johnstone United States
Charles Eigenbrot United States
Mindy I. Davis
Citations per year, relative to Mindy I. Davis Mindy I. Davis (= 1×) peers Charles Eigenbrot

Countries citing papers authored by Mindy I. Davis

Since Specialization
Citations

This map shows the geographic impact of Mindy I. Davis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mindy I. Davis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mindy I. Davis more than expected).

Fields of papers citing papers by Mindy I. Davis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mindy I. Davis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mindy I. Davis. The network helps show where Mindy I. Davis may publish in the future.

Co-authorship network of co-authors of Mindy I. Davis

This figure shows the co-authorship network connecting the top 25 collaborators of Mindy I. Davis. A scholar is included among the top collaborators of Mindy I. Davis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mindy I. Davis. Mindy I. Davis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ikeda, Yoshiki, Mindy I. Davis, Kazutaka Sumita, et al.. (2023). Multimodal action of KRP203 on phosphoinositide kinases in vitro and in cells. Biochemical and Biophysical Research Communications. 679. 116–121. 1 indexed citations
2.
Nasholm, Nicole, Amanda Balboni Iniguez, Matthew D. Hall, et al.. (2021). The synergy of BET inhibitors with aurora A kinase inhibitors in MYCN-amplified neuroblastoma is heightened with functional TP53. Neoplasia. 23(6). 624–633. 9 indexed citations
3.
Manz, Theresa, Adam Yasgar, Matthew D. Hall, et al.. (2019). Structure–Activity Relationship Study of Covalent Pan-phosphatidylinositol 5-Phosphate 4-Kinase Inhibitors. ACS Medicinal Chemistry Letters. 11(3). 346–352. 13 indexed citations
4.
Guenther, Lillian M., Neekesh V. Dharia, Linda S. Ross, et al.. (2018). A Combination CDK4/6 and IGF1R Inhibitor Strategy for Ewing Sarcoma. Clinical Cancer Research. 25(4). 1343–1357. 62 indexed citations
5.
Heske, Christine M., Mindy I. Davis, Joshua T. Baumgart, et al.. (2017). Matrix Screen Identifies Synergistic Combination of PARP Inhibitors and Nicotinamide Phosphoribosyltransferase (NAMPT) Inhibitors in Ewing Sarcoma. Clinical Cancer Research. 23(23). 7301–7311. 50 indexed citations
6.
Hall, Matthew D., Anton Simeonov, & Mindy I. Davis. (2016). Avoiding Fluorescence Assay Interference—The Case for Diaphorase. Assay and Drug Development Technologies. 14(3). 175–179. 17 indexed citations
7.
Davis, Mindy I., Min Shen, Anton Simeonov, & Matthew D. Hall. (2016). Diaphorase Coupling Protocols for Red-Shifting Dehydrogenase Assays. Assay and Drug Development Technologies. 14(3). 207–212. 16 indexed citations
8.
Merk, Alan, Alberto Bartesaghi, Soojay Banerjee, et al.. (2016). Breaking Cryo-EM Resolution Barriers to Facilitate Drug Discovery. Cell. 165(7). 1698–1707. 349 indexed citations
9.
Davis, Mindy I., Douglas S. Auld, & James Inglese. (2015). Bioluminescence Methods for Assaying Kinases in Quantitative High-Throughput Screening (qHTS) Format Applied to Yes1 Tyrosine Kinase, Glucokinase, and PI5P4Kα Lipid Kinase. Methods in molecular biology. 1360. 47–58. 7 indexed citations
10.
Davis, Mindy I., Atsuo T. Sasaki, & Anton Simeonov. (2015). Method for Assaying the Lipid Kinase Phosphatidylinositol-5-phosphate 4-kinase α in Quantitative High-Throughput Screening (qHTS) Bioluminescent Format. Methods in molecular biology. 1376. 1–9. 3 indexed citations
11.
Davis, Mindy I., Stefan Größ, Min Shen, et al.. (2014). Biochemical, Cellular, and Biophysical Characterization of a Potent Inhibitor of Mutant Isocitrate Dehydrogenase IDH1. Journal of Biological Chemistry. 289(20). 13717–13725. 72 indexed citations
12.
Rees, Matthew G., Mindy I. Davis, Min Shen, et al.. (2014). A Panel of Diverse Assays to Interrogate the Interaction between Glucokinase and Glucokinase Regulatory Protein, Two Vital Proteins in Human Disease. PLoS ONE. 9(2). e89335–e89335. 5 indexed citations
13.
Lea, Wendy, et al.. (2013). Literature Search and Review. Assay and Drug Development Technologies. 11(6). 347–354.
14.
Lea, Wendy, et al.. (2013). Literature Search and Review. Assay and Drug Development Technologies. 11(1). 1–8. 1 indexed citations
15.
Davis, Mindy I., Atsuo T. Sasaki, Min Shen, et al.. (2013). A Homogeneous, High-Throughput Assay for Phosphatidylinositol 5-Phosphate 4-Kinase with a Novel, Rapid Substrate Preparation. PLoS ONE. 8(1). e54127–e54127. 42 indexed citations
16.
Lea, Wendy, et al.. (2012). Literature Search and Review. Assay and Drug Development Technologies. 10(4). 297–312. 1 indexed citations
17.
Lea, Wendy, et al.. (2011). Literature Search and Review. Assay and Drug Development Technologies. 9(5). 436–454. 1 indexed citations
18.
Davis, Mindy I., Jeremy P. Hunt, Sanna Herrgård, et al.. (2011). Comprehensive analysis of kinase inhibitor selectivity. Nature Biotechnology. 29(11). 1046–1051. 1639 indexed citations breakdown →
19.
Wodicka, Lisa, Pietro Ciceri, Mindy I. Davis, et al.. (2010). Activation State-Dependent Binding of Small Molecule Kinase Inhibitors: Structural Insights from Biochemistry. Chemistry & Biology. 17(11). 1241–1249. 82 indexed citations
20.
Davis, Mindy I., M. J. Bennett, Leonard M. Thomas, & Pamela J. Björkman. (2005). Crystal structure of prostate-specific membrane antigen, a tumor marker and peptidase. Proceedings of the National Academy of Sciences. 102(17). 5981–5986. 223 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026